OGN vs USNA · P/E 3.4, rev $3.02B vs P/E 18, rev $473.5M
Organon & Co (OGN) versus USANA Health Sciences Inc (USNA) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
USANA Health Sciences Inc (USNA) is a packaged foods company listed on US.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported USNA revenue for 2026-07-04 was $473.5M. Net income was -$13.9M. Revenue was up 89.2% from 2026-04-04 to 2026-07-04. USNA currently screens at market cap $610.3M and trailing P/E 18.0.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. USNA currently screens at market cap $610.3M and trailing P/E 18.0.
Not investment advice. Open the OGN and USNA stock pages for the full models.
Not investment advice.